{"result": "(\"entity\"<|>MULTIDISCIPLINARY TEAM<|>ORGANIZATION<|>A multidisciplinary team is a group of healthcare professionals with various specialties working together to provide comprehensive care for patients with complex conditions, such as diabetes and its complications.)\n##\n(\"entity\"<|>DIABETIC NEUROPATHY<|>EVENT<|>Diabetic neuropathy is a type of nerve damage that can occur with diabetes, leading to complications such as Charcot foot due to loss of sensation in the feet.)\n##\n(\"entity\"<|>STATINS<|>EVENT<|>Statins are a class of drugs used to lower cholesterol levels in the blood, often prescribed to patients with cardiovascular disease, including those with diabetes.)\n##\n(\"entity\"<|>EMPAGLIFLOZINA<|>EVENT<|>Empagliflozina is a medication used to treat type 2 diabetes by helping to lower blood sugar levels and reduce cardiovascular risk.)\n##\n(\"relationship\"<|>DIABETIC NEUROPATHY<|>CHARCOT FOOT<|>Diabetic neuropathy can lead to the development of Charcot foot due to loss of protective sensation in the feet<|>8)\n##\n(\"relationship\"<|>MULTIDISCIPLINARY TEAM<|>CHARCOT FOOT<|>A multidisciplinary team is essential for managing Charcot foot, as it requires expertise from various medical fields<|>6)\n##\n(\"relationship\"<|>STATINS<|>DIABETES<|>Statins are often prescribed to patients with diabetes to manage cardiovascular risk factors<|>7)\n##\n(\"relationship\"<|>EMPAGLIFLOZINA<|>DIABETES<|>Empagliflozina is a treatment option for managing blood sugar levels in patients with diabetes<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: beneficios\n         o difusos se preferiría la RMN.                                                                                       individuales de una estabilización quirúrgica u otros procedimientos. El objetivo del trata-\n                                                                                                                               miento en pacientes con más enfermedades crónicas y lesiones articulares es mantener un\n         Referencias:                                                                                                          pie plantígrado estable, libre de ulceración e infección.\n         • Sequeira W. The neuropathic joint. Clin Exp Rheumatol. 1994 May-Jun;12(3):325-37.\n                                                                                                                               Referencias:\n                                                                                                                               • Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, et al. The Charcot foot in diabetes. Diabetes Care.\n                                                                                                                                 2011;34(9):2123-9.\n     84  El tratamiento de primera línea en este caso será:\n         A. Cirugía correctora con artrodesis.                                                                        2.6 Casos clínicos. Caso clínico 4\n         B. Inmovilización con descarga total de la extremidad.\n         C. Tratamiento con antibiótico parenteral.\n         D.  Administración de bisfosfonatos.                                                                           86     ¿Qué medida terapéutica le parece más importante en el momento actual?\n                                                                                                                               A. Valorar la adherencia al tratamiento e iniciar educación diabetológica para dieta, ejercicio\n         COMENTARIO                                                                                                                y autoanálisis de glucemias capilares junto con recomendación de abandono del\n         El tratamiento debe ser individualizado y llevado a cabo por un equipo multidisciplinar con                               consumo de tabaco.\n         experiencia en esta afección, incluidos los expertos médicos en enfermedades articulares                              B. Pedir una analítica con lípidos, HbA1c, cociente albúmina/creatinina.\n         y diabetes, y especialistas en cirugía de pie y tobillo y podología.                                                  C. Proponer IPCSK9.\n         La experiencia en terapia física también puede ser útil con la movilidad y los dispositivos                           D.  Añadir gliclazida.\n         para caminar. En la etapa activa aguda de la artropatía neuropática diabética, la descarga\n         del pie es la intervención más importante, y generalmente se realiza mediante el uso de un                            COMENTARIO\n         yeso de contacto total no removible. Los enfoques alternativos incluyen el uso de muletas\n         o una silla de ruedas.                                                                                                Se trata de un paciente con inicio de la DM2, en contexto de enfermedad cardiovascular\n                                                                                                                               establecida, por lo que está indicado cambio de estilo de vida, en contexto de educación\n         Referencias:                                                                                                          diabetológica.\n         • Petrova NL, Edmonds ME. Medical management of Charcot arthropathy. Diabetes Obes Metab. 2013;15(3):193-7.\n                                                                                                                               Los valores de HbA1c son de hace 1,5 meses y la HbA1c es un reflejo de la media de gluce-\n                                                                                                                               mias en los 3 meses previos.\n\n\n\n136                                                                                                                                                                                                                                                       137\n---\n                                                                                                                                                                                                                                       DIABETES                           2\n\n\n\n         El inicio de iPCSK9 queda supeditado a la no obtención de cifras adecuadas de colesterol LDL.                                  88  Señale la respuesta falsa:\n         La gliclazida no        nos va     a  aportar beneficios desde el punto de vista cardiovascular, con                               A. Si la estrategia de tratamiento se basara en la mínima pérdida progresiva de células β,\n         riesgo de hipoglucemias y ganancia ponderal.                                                                                            incluiría una tiazolidindiona.\n                                                                                                                                            B. Las gliflozinas son fármacos que se han de retirar antes de una cirugía.\n     87  ¿Cómo modificaría el tratamiento en este paciente de acuerdo consu riesgo                                                          C. Las glinidas se unen más a los receptores SUR2 que a los SURl.\n         cardiovascular?                                                                                                                    D.   Se puede mantener la empagliflozina si tras el inicio del tratamiento el filtrado glomerular\n         A. Optimización del tratamiento con estatinas teniendo en cuenta su probable intolerancia                                               baja a 55 ml/min.\n              previa a alguna de ellas.\n         B. Añadir empagliflozina.                                                                                                          COMENTARIO\n         C. Control de presión arterial ambulatoria (AMPA) y adecuación del tratamiento.                                                    El estudio ADOPT demostró que los cambios combinados favorables en la función de las\n         D.   Todas las respuestas son correctas.                                                                                           células β y la sensibilidad a la insulina a lo largo del tiempo con rosiglitazona parecían ser\n                                                                                                                                            responsables de su durabilidad glucémica superior a alternativas como la metformina y la\n                                                                                                                                            gliburida como monoterapia inicial en la DM2.\n         COMENTARIO                                                                                                                         En general, los secretagogos de insulina tienen mayor afinidad por la subunidad SUR1 pan-\n         La enfermedad cardiovascular (ECV) ateroesclerótica, definida como enfermedad corona-                                              creática respecto de la SUR2A y SUR2B card\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CHARCOT FOOT<|>EVENT<|>The Charcot foot is a condition that affects the foot and ankle, often seen in patients with diabetes, leading to joint damage and deformity.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic condition that affects how the body processes blood sugar (glucose), leading to various complications including cardiovascular disease.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes Mellitus Type 2 is a form of diabetes that is characterized by insulin resistance and relative insulin deficiency, often associated with obesity and lifestyle factors.)\n##\n(\"entity\"<|>PETROVA NL<|>PERSON<|>Petrova NL is a medical researcher who has contributed to the understanding of medical management of Charcot arthropathy in diabetes.)\n##\n(\"entity\"<|>EDMONDS ME<|>PERSON<|>Edmonds ME is a medical expert involved in the management of diabetic foot complications, including Charcot arthropathy.)\n##\n(\"relationship\"<|>CHARCOT FOOT<|>DIABETES<|>Charcot foot is a complication that can arise from diabetes, particularly in patients with neuropathy<|>8)\n##\n(\"relationship\"<|>DIABETES MELLITUS TYPE 2<|>DIABETES<|>Diabetes Mellitus Type 2 is a specific type of diabetes that falls under the broader category of diabetes<|>9)\n##\n(\"relationship\"<|>PETROVA NL<|>CHARCOT FOOT<|>Petrova NL has researched the medical management of Charcot foot, contributing to its understanding in diabetic patients<|>7)\n##\n(\"relationship\"<|>EDMONDS ME<|>CHARCOT FOOT<|>Edmonds ME is involved in the management of diabetic foot complications, including Charcot foot<|>7)\n<|COMPLETE|>"}]}